Tempus | AI-Powered Precision Medicine & Genomic Testing
Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Tempus Hub
Tempus Hub provides a secure platform for managing your Tempus-related activities and information.
Tempus AI - Wikipedia
Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …
Tempus and Blood Cancer United® Announce Collaboration to …
1 day ago · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma …
Tempus AI, Inc. (TEM) Announces Strategic Deal with Merck to Fast …
Mar 7, 2026 · Tempus AI, Inc. (NASDAQ:TEM) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. On March 3, the company announced a strategic partnership with Merck to fast-track …
Tempus | Accounts
Trouble logging in?
Clear Street Group Inc. Acquires Stake in Tempus AI
3 days ago · The acquisition of a significant stake in Tempus AI by Clear Street Group, a prominent investment firm, signals confidence in the potential of the AI-driven healthcare company. Tempus …
TEM | Tempus AI Inc. Stock Overview (U.S.: Nasdaq) | Barron's
1 day ago · Complete Tempus AI Inc. stock information by Barron's. View real-time TEM stock price and news, along with industry-best analysis.
FinancialContent - Tempus and Blood Cancer United® Announce ...
11 hours ago · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma …
Should You Buy, Hold or Sell Tempus AI Stock Heading Into 2026?
Mar 9, 2026 · TEM eyes 2026 growth by scaling diagnostics, MRD testing and AI-driven clinical apps as revenues surge 83%, though valuation concerns temper the outlook.